Neurosciences

Title
RESPOND CRT
Trial Number
205731091813
Number of Participants
1,032
Principal Investigator

Peter Santucci

M.D., FACC, FAHA
Cardiology
Professor
Eligibility

Patients with heart failure that meet current indication for cardiac resynchronization therapy.

Purpose

The purpose of this study is to test both the good and bad effects of using an investigational right atrium lead and CRT-D device during cardiac resynchronization therapy. The right atrium lead has a sensor that will automatically calculate the best time to pace the heart. The study will compare the responses to CRT-D therapy in patients receiving the automatic optimization in the device or by an echocardiogram.

Enrollment

(708) 216-2644

MORE CLINICAL TRIALS

Clinical Trials

For more information call (888) LUHS-888.